Xiaofeng Ding

1.3k total citations
42 papers, 974 citations indexed

About

Xiaofeng Ding is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xiaofeng Ding has authored 42 papers receiving a total of 974 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 14 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Xiaofeng Ding's work include MicroRNA in disease regulation (6 papers), Ubiquitin and proteasome pathways (6 papers) and RNA modifications and cancer (6 papers). Xiaofeng Ding is often cited by papers focused on MicroRNA in disease regulation (6 papers), Ubiquitin and proteasome pathways (6 papers) and RNA modifications and cancer (6 papers). Xiaofeng Ding collaborates with scholars based in China, United States and Macao. Xiaofeng Ding's co-authors include Shuanglin Xiang, Xiang Hu, Jianlin Zhou, Chang Zhou, Xing Zhang, Xin Yang, Meilian Liu, Yan Luo, Yuzhong Xiao and Xuexian O. Yang and has published in prestigious journals such as The Journal of Experimental Medicine, PLoS ONE and Scientific Reports.

In The Last Decade

Xiaofeng Ding

39 papers receiving 968 citations

Peers

Countries citing papers authored by Xiaofeng Ding

Since Specialization

Citations

This map shows the geographic impact of Xiaofeng Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofeng Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofeng Ding more than expected).

Fields of papers citing papers by Xiaofeng Ding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofeng Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofeng Ding. The network helps show where Xiaofeng Ding may publish in the future.

Co-authorship network of co-authors of Xiaofeng Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofeng Ding. A scholar is included among the top collaborators of Xiaofeng Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofeng Ding. Xiaofeng Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	METTL3 inhibition promotes radiosensitivity in hepatocellular carcinoma through regulation of SLC7A11 expression 2025 ·Cell Death and Disease ·Chen Zhang, (unknown), Hanbin Chen, Xiaofeng Ding, Huajian Chen, Zhenzhen Liang, Yinlong Zhao, Shumei Ma, Xiaodong Liu	4
2	Biological and Bioinspired Vesicles for Wound Healing: Insights, Advances and Challenges 2025 ·International Journal of Nanomedicine ·Yingchao Zhao, (unknown), (unknown), Jiangwei Lu, Xinyue Zhang, (unknown), Zhongjian Chen, Xiaofeng Ding, Zongguang Tai	0
3	The safety and effectiveness of tDCS for epileptic patients: A systematic review and meta-analysis 2025 ·Complementary Therapies in Medicine ·Xiaofeng Ding, Mingyu Hu, Chi Wang, Wonseok Kang, Jinzhao Huang, Ruiyu Wang, Qing Shen, (unknown)	2
4	Invasive Group A Streptococcus Hypervirulent M1_UK Clone, Canada, 2018–2023 2024 ·Emerging infectious diseases ·Alyssa Golden, (unknown), Gregory J. Tyrrell, Julianne V. Kus, Allison McGeer, Marc-Christian Domingo, (unknown), (unknown), Paul Van Caeseele, Guillaume Desnoyers, David Haldane, Yang Yu, Xiaofeng Ding, (unknown), (unknown), (unknown), Irene Martín	4
5	Epigenetically modified AP-2α by DNA methyltransferase facilitates glioma immune evasion by upregulating PD-L1 expression 2023 ·Cell Death and Disease ·(unknown), Gui‐Xiang Huang, Mi Ouyang, Kai Xiao, Hao Zhou, (unknown), Zhiwei Li, Zhe Zhong, (unknown), (unknown), Shuanglin Xiang, Xiaofeng Ding	21
6	P2.09-36 Efficacy and Safety of Furmonertinib 160 mg as First-line Therapy for EGFR-mutated Advanced NSCLC Patients with CNS Metastases 2023 ·Journal of Thoracic Oncology ·Xiuli Zheng, Jun An, Hua Yang, Xiaofeng Ding, Shaowei Sun, (unknown), (unknown), Weihong Xu, Wei Feng, Kun Wang, (unknown)	1
7	Adipocyte-derived PGE2 is required for intermittent fasting–induced Treg proliferation and improvement of insulin sensitivity 2022 ·JCI Insight ·Chunqing Wang, Xing Zhang, Liping Luo, Yan Luo, Xin Yang, Xiaofeng Ding, Lu Wang, (unknown), (unknown), (unknown), (unknown), Wendong Huang, Yingmei Feng, Feng Liu, Xuexian O. Yang, Meilian Liu	19
8	Adiponectin restrains ILC2 activation by AMPK-mediated feedback inhibition of IL-33 signaling 2020 ·The Journal of Experimental Medicine ·Lu Wang, Yan Luo, Liping Luo, Dandan Wu, Xiaofeng Ding, Handong Zheng, (unknown), (unknown), Xin Yang, (unknown), Chunqing Wang, Xing Zhang, (unknown), Jindong Chen, Jonathan L. Brigman, Michael A. Mandell, Zhiguang Zhou, Feng Liu, Xuexian O. Yang, Meilian Liu	46
9	Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma 2020 ·EBioMedicine ·Ye Xiao, (unknown), (unknown), Xiaofeng Ding, Yi Sun, Chenxi Wei, Xiang Hu, Ke Wei, (unknown), Lina Xie, (unknown), Wen Chen, Zhijian Zhang, Ning Liu, Shuanglin Xiang	34
10	Sustained activation of autophagy suppresses adipocyte maturation via a lipolysis-dependent mechanism 2019 ·Autophagy ·Xing Zhang, Dandan Wu, Chunqing Wang, Yan Luo, Xiaofeng Ding, Xin Yang, (unknown), (unknown), John Weaver, Michael A. Mandell, Vojo Deretić, Meilian Liu	36
11	Epidermal growth factor promotes intestinal secretory cell differentiation in weaning piglets via Wnt/β-catenin signalling 2019 ·animal ·Lixiang Wang, Fan Zhu, Jianli Li, (unknown), Xiaofeng Ding, Jia Yin, Xia Xiong, Huansheng Yang	23
12	Adipose mTORC1 Suppresses Prostaglandin Signaling and Beige Adipogenesis via the CRTC2-COX-2 Pathway 2018 ·Cell Reports ·Xing Zhang, Yan Luo, Chunqing Wang, Xiaofeng Ding, Xin Yang, Dandan Wu, (unknown), Zijiang Yang, Qin Zhou, Lu Wang, Xiaoqing Wang, Jianlin Zhou, (unknown), Michael Spafford, Mark R. Burge, Xuexian O. Yang, Meilian Liu	56
13	KCTD10 Is Involved in the Cardiovascular System and Notch Signaling during Early Embryonic Development 2014 ·PLoS ONE ·Kaiqun Ren, Jing Yuan, Manjun Yang, Xiang Gao, Xiaofeng Ding, Jianlin Zhou, Xingwang Hu, Jianguo Cao, Xiyun Deng, Shuanglin Xiang, Jian Zhang	27
14	Eps8 regulates cellular proliferation and migration of breast cancer 2014 ·International Journal of Oncology ·Cheng Chen, (unknown), Wenhuan Huang, Xinxin Li, Fangliang Zhou, Xiang Hu, Mei Han, Xiaofeng Ding, Shuanglin Xiang	36
15	MicroRNA-373 is upregulated and targets TNFAIP1 in human gastric cancer, contributing to tumorigenesis 2013 ·Oncology Letters ·Xiaoting Zhang, Xiaofeng Li, (unknown), (unknown), (unknown), Xiaofeng Ding, Xiang Hu, Jianlin Zhou, Shuanglin Xiang, Chang Zhou, Jian Zhang	31
16	Eps8 promotes cellular growth of human malignant gliomas 2012 ·Oncology Reports ·Xiaofeng Ding, Fangliang Zhou, (unknown), (unknown), Chang Zhou, Jianlin Zhou, Bo Zhang, Junmei Yang, Guangwei Wang, Wei Zheng, Xiang Hu, Shuanglin Xiang, Jian Zhang	22
17	A miR-200b/200c/429-Binding Site Polymorphism in the 3′ Untranslated Region of the AP-2α Gene Is Associated with Cisplatin Resistance 2011 ·PLoS ONE ·Yuan Wu, Yuzhong Xiao, Xiaofeng Ding, (unknown), Peng Ren, Chang Zhou, Jianlin Zhou	72
18	Identification and characterization of the novel protein CCDC106 that interacts with p53 and promotes its degradation 2010 ·FEBS Letters ·Jianlin Zhou, (unknown), Ling Xiao, Wei Sun, Lin Wang, Hong Li, Yuan Wu, Xiaofeng Ding, Xiang Hu, Chang Zhou, (unknown)	21
19	Human ZCCHC12 activates AP-1 and CREB signaling as a transcriptional co-activator 2009 ·Acta Biochimica et Biophysica Sinica ·Hong Li, Qian Liu, Xiang Hu, Feng Du, Shuanglin Xiang, Zhicheng He, Xingwang Hu, Jianlin Zhou, Xiaofeng Ding, Chang Zhou, Jian Zhang	12
20	The interaction of KCTD1 with transcription factor AP‐2α inhibits its transactivation 2008 ·Journal of Cellular Biochemistry ·Xiaofeng Ding, Chang Luo, Jianlin Zhou, Yingli Zhong, Xiang Hu, Fangliang Zhou, Kaiqun Ren, Lu Gan, (unknown), (unknown), Xiang Gao, Jian Zhang	49

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact